CTC
RDY icon

Central Trust Company’s Dr. Reddy's Laboratories RDY Stock Holding History

Central Trust Company’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-400
Closed -$6.1K – 1503
2024
Q2 		$6.1K Buy
+400
New +$5.73K ﹤0.01% 1143
2017
Q3 		– Sell
-1,000
Closed -$8K – 1335
2017
Q2 		$8K Buy
+1,000
New +$8.13K ﹤0.01% 980
2014
Q4 		– Sell
-740
Closed -$8K – 1223
2014
Q3 		$8K Hold
740
– – ﹤0.01% 1016
2014
Q2 		$6K Hold
740
– – ﹤0.01% 1038
2014
Q1 		$6K Buy
+740
New +$6.44K ﹤0.01% 1036

Other funds holding RDY

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Central Trust Company's RDY Position: Q3 2024 in Review

Central Trust Company sold out of Dr. Reddy's Laboratories (RDY) in Q3 2024, closing a stake of 400 shares — an estimated $6.1K sold.

Central Trust Company first reported a position in RDY in Q1 2014 and held it in 5 quarters. The position peaked at $8K in Q2 2017. 228 funds tracked by Wall St. Rank hold RDY as of Q3 2024.

  • Central Trust Company reported no remaining Dr. Reddy's Laboratories position as of Q3 2024 after selling out during the quarter.
  • Central Trust Company sold 400 Dr. Reddy's Laboratories shares in Q3 2024, an estimated $6.1K.
  • Central Trust Company first reported a position in Dr. Reddy's Laboratories in Q1 2014 and held it in 5 quarters.
  • Central Trust Company's Dr. Reddy's Laboratories position peaked at $8K in Q2 2017.
  • 228 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2024.

Based on Central Trust Company's 13F filing for Q3 2024, filed 22 Oct 2024.